Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AemetisAMTX +7.28%37 12-1 Month Momentum % is -40.86% as of Aug. 04, 2026. GuruFocus rates AMTX with a GF Score™ of 37/100 and a GF Value™ of $2.17 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,607 Chemicals companies, Aemetis ranks worse than 92.66% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-04), Aemetis's 12-1 Month Momentum % is -40.86%.
The industry rank for Aemetis's 12-1 Month Momentum % or its related term are showing as below:
AMTX's 12-1 Month Momentum % is ranked worse than 92.66% of 1607
companies
in the Chemicals industry
Industry Median: 3.55
vs AMTX: -40.86
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Aemetis 12-1 Month Momentum % Related Terms
AMTX vs KBLB, NTIC, FSI: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Aemetis's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aemetis 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aemetis's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Aemetis's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -40.86% mean?
Aemetis (AMTX) has a 12-1 Month Momentum % of -40.86% as of Aug. 04, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Aemetis and its competitors. According to the industry distribution chart, Aemetis ranks #1489 out of 1607 companies in the Chemicals industry, placing it in the top 92.7%.
Is Aemetis' 12-1 Month Momentum % too high?
Aemetis' current 12-1 Month Momentum % is -40.86%. Based on the distribution chart, Aemetis ranks #1489 out of 1607 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Aemetis has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aemetis' 12-1 Month Momentum % compare to KBLB and NTIC?
According to the Chemicals industry distribution chart, Aemetis ranks #1489 out of 1607 companies for 12-1 Month Momentum %. This places Aemetis in the lower half of its industry. The industry median 12-1 Month Momentum % is 3.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
The median 12-1 Month Momentum % among Chemicals companies is 3.55, based on 1,607 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Aemetis and its competitors. For the Chemicals industry, the median 12-1 Month Momentum % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aemetis's current 12-1 Month Momentum % is -40.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aemetis stock overvalued right now?
Based on GuruFocus' analysis, Aemetis (AMTX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.17, compared to a current price of $1.62 — trading 25.3% below its estimated fair value. The current 12-1 Month Momentum % is -40.86%. Aemetis' overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Aemetis (AMTX), the current 12-1 Month Momentum % is -40.86% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aemetis (AMTX) Overvalued in 2026?
Based on GuruFocus' analysis, Aemetis stock appears to be undervalued.
The current stock price of $1.62 is trading 25.3% below its estimated GF Value™ of $2.17.
GuruFocus considers Aemetis to be Modestly Undervalued.
Key valuation signals for AMTX:
12-1 Month Momentum %: -40.86%
GF Value™: $2.17 vs. price of $1.62 (25.3% below fair value)
No single metric tells the full story. See the AMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
37GF Score
Get the complete analysis for AMTX
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMTX has been successfully added to your 
